SBIR/STTR Research Award
A method for sterilization of human plasma and platelets
Award amount
$0Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AMULET PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): This proposal is to develop a method to
prolong the shelf-life and increase the safety of human platelets with a unique
method of sterilization. The method delivers an agent known to kill a range of
microbial pathogens in vitro including many bacterial species known to
contaminate platelet concentrates, fungi, parasites, and viruses. The lethal
agent can be released from an insoluble polymer that can be incorporated into
the plastic that comprises the collection bag. The microbicide breaks down
rapidly to normal physiological by-products, presenting little danger to the
patient. Successful development of this method will increase the safety of the
platelet and plasma supply, and, by inhibiting microbial growth, increase the
shelf-life of platelets.
The focus of the effort will be to develop a storage container made from
polymers that release sufficient quantities of the lethal agent. Alternative
strategies include increasing the polymer surface area, via alterations in the
storage container, that will allow release of sufficient lethal agent for
efficacy. Antimicrobial spectra of the lethal agent will continue to be
assessed before and during prototype stages. Physiological assessments of the
effects of the lethal agent on platelets will be performed. Prototype
containers will be tested under blood bank conditions.
PROPOSED COMMERCIAL APPLICATION:
Not Available
Technology keywords
Not reported